AGC Biologics is hosting a fireside chat on gene therapy development this month with special guest lecture partners!

ATMP companies must adapt their business approaches to secure additional resources and improve cost-effectiveness to remain competitive in a down market. On top of that, there are changes in how regulators are evaluating these new drug products at each key stage of development.

This discussion is designed to equip the industry with important insights for 2024.

Don’t miss the opportunity to register – limited space available!